Financial Implications of Prostate Magnetic Resonance Imaging Without Contrast.

Pockros, Benjamin; Davenport, Matthew; Mead, Mitchell; Talwar, Ruchika; Kaffenberger, Samuel; Sekar, Rishi; Ibrahim, Andrew; Morgan, Todd M

Pockros, Benjamin; Davenport, Matthew; Mead, Mitchell; Talwar, Ruchika; Kaffenberger, Samuel; Sekar, Rishi; Ibrahim, Andrew; Morgan, Todd M.

Afiliação

Pockros B; Department of Urology, University of Michigan, Ann Arbor, Michigan.
Davenport M; Department of Urology, University of Michigan, Ann Arbor, Michigan.
Mead M; Department of Radiology, University of Michigan, Ann Arbor, Michigan.
Talwar R; School of Medicine, University of Michigan, Ann Arbor, Michigan.
Kaffenberger S; Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee.
Sekar R; Department of Urology, University of Michigan, Ann Arbor, Michigan.
Ibrahim A; Department of Urology, University of Michigan, Ann Arbor, Michigan.
Morgan TM; Department of Surgery, University of Michigan, Ann Arbor, Michigan.

Urol Pract ; 11(6): 915-917, 2024 Nov.

Article em En | MEDLINE | ID: mdl-39196665

Palavras-chave

MRI; access to care; active surveillance; financial toxicity; prostate cancer

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Urol Pract Ano de publicação: 2024 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google